Masaru Yamamoto
Affiliations: | University of Nebraska Medical Center, Omaha, NE, United States |
Google:
"Masaru Yamamoto"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yamamoto M, Ikezu T. (2011) CCR2 chemokine receptor Xpharm: the Comprehensive Pharmacology Reference. 1-7 |
| Yamamoto M, Ikezu T. (2011) CCR1 chemokine receptor Xpharm: the Comprehensive Pharmacology Reference. 1-10 |
| Kiyota T, Yamamoto M, Schroder B, et al. (2009) AAV1/2-mediated CNS Gene Delivery of Dominant-negative CCL2 Mutant Suppresses Gliosis, β-amyloidosis, and Learning Impairment of APP/PS1 Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 803-809 |
| Kiyota T, Yamamoto M, Xiong H, et al. (2009) CCL2 accelerates microglia-mediated Abeta oligomer formation and progression of neurocognitive dysfunction. Plos One. 4: e6197 |
| Kiyota T, Yamamoto M, Schroder B, et al. (2009) AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 803-9 |
| Yamamoto M, Kiyota T, Walsh SM, et al. (2008) Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes. Journal of Immunology (Baltimore, Md. : 1950). 181: 3877-86 |
| Yamamoto M, Ramirez SH, Sato S, et al. (2008) Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. The American Journal of Pathology. 172: 521-33 |
| Ikezu T, Kiyota T, Yamamoto M, et al. (2008) O1-04-08: Therapeutic application of anti-inflammatory cytokines an Abeta-induced cognitive dysfunction Alzheimer's & Dementia. 4: T116-T117 |
| Yamamoto M, Kiyota T, Walsh SM, et al. (2007) Kinetic analysis of aggregated amyloid-beta peptide clearance in adult bone-marrow-derived macrophages from APP and CCL2 transgenic mice. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 2: 213-21 |
| Yamamoto M, Kiyota T, Horiba M, et al. (2007) Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice. The American Journal of Pathology. 170: 680-92 |